(2S)-2-phenyl-2-[[6-[2-(trideuteriomethoxy)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethanol
C21H20N4O2 — CID 162670630
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-2-phenyl-2-[[6-[2-(trideuteriomethoxy)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethanol
(2S)-2-phenyl-2-[[6-[2-(trideuteriomethoxy)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethanol (PubChem CID 162670630) has the molecular formula C21H20N4O2 and a molecular weight of 363.44 g/mol. Its IUPAC name is (2S)-2-phenyl-2-[[6-[2-(trideuteriomethoxy)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethanol.
Molecular Properties
| Compound Name | (2S)-2-phenyl-2-[[6-[2-(trideuteriomethoxy)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethanol |
|---|---|
| PubChem CID | 162670630 |
| Molecular Formula | C21H20N4O2 |
| Molecular Weight | 363.44 g/mol |
| Exact Mass | 363.18 |
| IUPAC Name | (2S)-2-phenyl-2-[[6-[2-(trideuteriomethoxy)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethanol |
| SMILES | [2H]C([2H])([2H])Oc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1 |
| InChI | InChI=1S/C21H20N4O2/c1-27-19-10-6-5-9-15(19)17-11-16-20(24-17)22-13-23-21(16)25-18(12-26)14-7-3-2-4-8-14/h2-11,13,18,26H,12H2,1H3,(H2,22,23,24,25)/t18-/m1/s1/i1D3 |
| InChIKey | HXSDKMUJXCRATG-HLENTGRASA-N |
| XLogP | 3.78 |
| TPSA | 83.06 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 363.44 |
| LogP ≤ 5 | 3.78 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162670630 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.